Indication
Sitosterolemia
Sitosterolemia is a rare autosomal recessive metabolic disorder of lipid trafficking characterized by hyperabsorption and impaired biliary excretion of dietary plant sterols, such as sitosterol and campesterol. Read more about Sitosterolemia
23 drugs 23 manufacturers
Drugs that treat it
Common Sitosterolemia therapies.
EZETIMIBE
EZETIMIBE
ZETIA (ezetimibe)
EZETIMIBE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSitosterolemia is a rare autosomal recessive metabolic disorder of lipid trafficking characterized by hyperabsorption and impaired biliary excretion of dietary plant sterols, such as sitosterol and campesterol.
The disease arises from biallelic loss-of-function variants in either the ABCG5 or ABCG8 genes, which encode the ABC transporter complex responsible for effluxing plant sterols and non-cholesterol sterols from enterocytes and hepatocytes.
Affected individuals accumulate markedly elevated plasma and tissue concentrations of phytosterols, primarily impacting the cardiovascular, musculoskeletal, and hematologic systems.
Defining clinical features often present in childhood or young adulthood and include tendon and tuberous xanthomas, accelerated atherosclerosis leading to premature coronary artery disease, arthralgias, and hematologic anomalies such as hemolytic anemia and macrothrombocytopenia.
- nih.gov
Sitosterolemia is a rare autosomal recessive metabolic disorder of lipid trafficking characterized by hyperabsorption and impaired biliary excretion of dietary plant sterols, such as sitosterol and campesterol The disease arises from biallelic loss-of-function variants in either the ABCG5 or ABCG8 genes, which encode the ABC transporter complex responsible for effluxing plant sterols and non-cholesterol sterols from enterocytes and hepatocytes Defining clinical features often present in childhoo...
- nih.gov
Sitosterolemia is a rare autosomal recessive metabolic disorder of lipid trafficking characterized by hyperabsorption and impaired biliary excretion of dietary plant sterols, such as sitosterol and campesterol The disease arises from biallelic loss-of-function variants in either the ABCG5 or ABCG8 genes, which encode the ABC transporter complex responsible for effluxing plant sterols and non-cholesterol sterols from enterocytes and hepatocytes Defining clinical features often present in childhoo...
- medlineplus.gov
Affected individuals accumulate markedly elevated plasma and tissue concentrations of phytosterols, primarily impacting the cardiovascular, musculoskeletal, and hematologic systems
- nih.gov
Affected individuals accumulate markedly elevated plasma and tissue concentrations of phytosterols, primarily impacting the cardiovascular, musculoskeletal, and hematologic systems Defining clinical features often present in childhood or young adulthood and include tendon and tuberous xanthomas, accelerated atherosclerosis leading to premature coronary artery disease, arthralgias, and hematologic anomalies such as hemolytic anemia and macrothrombocytopenia
Personalize your experience
Follow Sitosterolemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.